Search Results 601-610 of 17281 for GLP-1 therapy
... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.
... treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials ...
... one or both of the medicines. ... Before having any kind of surgery, dental treatment, or emergency treatment ... You may report side effects to the FDA at 1-800- ...
This slow-growing blood cancer mainly affects people over 60. Treatments and lifestyle changes may reduce complications and ease symptoms.
... Treatment. Print details. Share; Facebook ... treatment works better than the current standard therapy. ... The purpose of phase 1 of this trial is to ...
... treatment for metastatic breast cancer. This medicine is also used with other cancer medicines (eg, trastuzumab) as a neoadjuvant treatment ... 1-800-FDA-1088.
... therapy. CAR-T cell therapy is fast-acting, showing evidence of response within one to three months. It stands out among similar cancer therapies in terms ...
... therapy with pegylated interferon and RBV. The primary study hypothesis is ... The treatment duration will be 1 day. Subjects will be monitored for ...
- Cohort A: Received a minimum of 1 to a maximum of 3 prior lines of therapy including a proteasome inhibitor (PI) and immunomodulatory therapy (IMiD), and ...
Children—Use and dose must be determined by your doctor. For treatment of acute deep vein thrombosis with or without pulmonary embolism: Adults—Dose is based on ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!